05 Wednesday Jul 2017
Posted in Current Perspectives
According to a 2014 report by the Tufts Center for the Study of Drug Development, the cost of developing a new drug is $2.6 billion. That is a 145% increase, adjusted for inflation, over their 2003 estimates. This report has been criticized and praised, but the reality is that developing a new drug is an expensive and time consuming process (on an average it takes 12 years to go from discovery to commercialization).
Continue reading
28 Tuesday May 2013
Posted in Breaking Pharmaceutical News
Tags
Abimbola Farinde, Pharm.D., is a clinical pharmacist specialist with specializations in psychopharmacology and geriatrics.In an effort to increase the probability of effectively treating hyperlipidemia, the Food and Drug Administration (FDA) recently approved another lipid lowering agent, Merck’s Liptruzet (ezetimibe and atorvastatin). The approval of this “me-too” drug adds to the growing list of available therapeutic options that specifically target the management of primary or mixed hyperlipidemia as an adjunctive therapy to diet when diet alone does not successfully lower cholesterol.
